Pharma BD Deal Intelligence
BioTransplant Inc. / Eligix Inc.
2001 · Acquisition/Merger · $55M · Complete
Announcement Sentiment
64
Positive
6.6M BioTransplant shares for Eligix. Below $250M threshold but strategically notable: Harvard-affiliated cell-therapy/stem-cell graft purification (BCell-HDM, TCell-HDM).
Key facts
- Announced May 16, 2001
- Deal value $55M
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals